383419-78-1Relevant articles and documents
Partially hydrogenated aryl-1,2/1,4-anthraquinone derivatives, 5-lipoxygenase inhibitors with arotinoid structure
Wurm,Probst,Schwandt
, p. 527 - 533 (2007/10/03)
The combination of 5-LOX inhibition and retinoid activity in one molecule could be an interesting pharmacological tool to influence psoriasis. Thus we synthezised compounds with arotinoid structure by anellation of the 5-LOX inhibitors 1 and 2 with 1,1,4,